Copyright
©2013 Baishideng Publishing Group Co.
World J Diabetes. Dec 15, 2013; 4(6): 245-255
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.245
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.245
Stage 1 Early hyperfunction and hypertrophy | ACR < 30 mg/g creatinine |
Stage 2 Morphologic lesions without signs of clinical disease | ACR > 30 and < 300 mg/g creatinine |
Stage 3 Microalbuminuria | ACR > 300 mg/g creatinine and/or persistent |
proteinuria with serum concentration of creatinine 2.0 mg/dL | |
Stage 4 Overt nephropathy | Serum concentration of creatinine 2.0 mg/dL with proteinuria |
Stage 5 End-stage renal disease with uremia | On dialysis |
Ref. | Country | Population | Type 1 or 2 DM | % DN | % NDRD | % Mixed |
Mazzucco et al[23] | Italy | 393 | 2 | 39.7 | 43 | 17.3 |
Christensen et al[24] | Denmark | 51 | 2 | 68.6 | 13.8 | NR |
Zhang et al[37] | China | 130 | 2 | 73.9 | 26.1 | NR |
Zhuo et al[50] | China/Japan | 216 | 2 | 6.5 | 82.9 | 10.7 |
Sharma et al[51] | United States | 620 | 2 | 37 | 36 | 27 |
Hironaka et al[52] | Japan | 35 | 1 and 2 | 71.4 | 14.3 | 14.3 |
Wong et al[53] | China | 68 | 2 | 35 | 46 | 19 |
Prakash et al[55] | India | 23 | 2 | 56.5 | 30.5 | 13 |
Mak et al[56] | China | 51 | 2 | 67 | 16 | 17 |
Biensebach et al[57] | Austria | 84 | 2 | 78.5 | 21.5 | NR |
Richards et al[58] | United Kingdom | 68 | 1 and 2 | 61 | 32 | 3 |
Parving et al[59] | Denmark | 35 | 2 | 77.1 | 20 | 2.9 |
Cordonnier et al[60] | United Kingdom | 26 | 2 | 85 | 15 | NR |
Nzerue et al[61] | United States | 31 | 2 | 41.9 | 19.4 | 38.7 |
Lee et al[62] | South Korea | 22 | 2 | 36.4 | 50 | 13.6 |
Izzedine et al[63] | France | 21 | 1 and 2 | 62 | 38 | NR |
Castellano et al[64] | Spain | 20 | 2 | 45 | 55 | NR |
Serra et al[65] | Spain | 35 | 2 | 74.3 | 17.2 | 8.5 |
Premalatha et al[66] | India | 18 | 2 | 50 | 50 | NR |
Rychlík et al[67] | Czech Republic | 163 | 2 | 42.4 | 47.5 | 10.1 |
Tone et al[68] | Japan | 97 | 2 | 36 | 16.5 | 47.5 |
Moger et al[69] | India | 26 | 2 | 34.6 | 23.1 | 42.3 |
Soni et al[70] | India | 160 | 2 | 42.5 | 27.5 | 30 |
Pham et al[71] | United States | 233 | 2 | 27.5 | 53.2 | 19.3 |
Kharrat et al[72] | Tunisia | 72 | 2 | 34.1 | 69.5 | NR |
Akimoto et al[73] | Japan | 50 | 2 | 68 | 26 | 6 |
Huang et al[74] | China | 52 | 2 | 55.7 | 38.5 | 5.8 |
Lin et al[75] | Taiwan, China | 50 | 2 | 48 | 22 | 30 |
Ghani et al[76] | Kuwait | 31 | 2 | 54.8 | NR | 45.2 |
Arif et al[77] | Pakistan | 73 | 2 | 27.3 | 49.3 | NR |
Hashim Al-Saedi et al[78] | Iraq | 80 | 1 and 2 | NR | NR | 100 |
Mou et al[79] | China | 69 | 2 | 47.8 | 52.2 | NR |
Haider et al[80] | Austria | 567 | 1 and 2 | 68 | 17.4 | NR |
Chang et al[81] | South Korea | 119 | 2 | 36.2 | 53.8 | 10 |
Bi et al[82] | China | 220 | 2 | 54.5 | NR | 45.5 |
Chong et al[83] | Malaysia | 110 | 2 | 62.7 | 18.2 | 19.1 |
Harada et al[84] | Japan | 55 | 2 | 54.5 | 34.5 | 10.9 |
Oh et al[85] | South Korea | 126 | 2 | 39.7 | 51.6 | 8.7 |
Yaqub et al[86] | Pakistan | 68 | 2 | 31 | 52 | 17 |
- Citation: Gonzalez Suarez ML, Thomas DB, Barisoni L, Fornoni A. Diabetic nephropathy: Is it time yet for routine kidney biopsy? World J Diabetes 2013; 4(6): 245-255
- URL: https://www.wjgnet.com/1948-9358/full/v4/i6/245.htm
- DOI: https://dx.doi.org/10.4239/wjd.v4.i6.245